A Study to Evaluate the Efficacy and Safety of ICP-488 in Participants With Primary Sjögren's Syndrome
Clinical trial NCT07727486 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07727486
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-12-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.